Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA

Showing 4 posts of 1444 posts found.

Blow for Genzyme as FDA finds fault with Allston facility

March 13, 2009
Research and Development, Sales and Marketing FDA, Genzyme

The chances of approval for Genzyme's new Pompe disease drug Lumizyme have diminished dramatically after the US Food and Drug …

News

FDA finalises transgenic animals guide

January 23, 2009
Research and Development, Sales and Marketing FDA, US, reg

The route map for companies wishing to sell medicines made in genetically-engineered animals has been drawn up by the FDA. …

News

FDA moves to make imports safer

January 16, 2009
Manufacturing and Production FDA, supply chain

The Food and Drug Administration is stepping up efforts to prevent counterfeit and contaminated  medicines entering the US, and is …

News

Novartis’ Zelnorm pulled from market after safety concerns

April 2, 2007
Sales and Marketing FDA, reg

Zelnorm, the treatment for irritable bowel syndrome, has been withdrawn from the US market after the FDA raised concerns about …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026